Indo Rama Synthetics India Ltd vs Skybiotech Healthcare Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 28, 2026

Key Highlights

The Latest Trading Price of Indo Rama Synthetics (India) Ltd is ₹ 45.43 as of 25 Jun 15:30 . The P/E Ratio of Indo Rama Synthetics (India) Ltd changed from 9 on March 2021 to 680.8 on March 2025 . This represents a CAGR of 137.55% over 5 yearsThe P/E Ratio of Skybiotech Healthcare Limited changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Indo Rama Synthetics (India) Ltd changed from ₹ 1015 crore on March 2021 to ₹ 888.83 crore on March 2025 . This represents a CAGR of -2.63% over 5 yearsThe Market Cap of Skybiotech Healthcare Limited changed from ₹ 31.33 crore on March 2025 to ₹ 31.33 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Indo Rama Synthetics (India) Ltd for the Mar '26 is ₹ 1206 crore as compare to the Dec '25 revenue of ₹ 1191 crore. This represent the growth of 1.32% The revenue of Skybiotech Healthcare Limited for the Mar '26 is ₹ 1.98 crore as compare to the Dec '25 revenue of ₹ 1.04 crore. This represent the growth of 90.38% The ebitda of Indo Rama Synthetics (India) Ltd for the Mar '26 is ₹ 107.6 crore as compare to the Dec '25 ebitda of ₹ 56.87 crore. This represent the growth of 89.2% The ebitda of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.73 crore as compare to the Dec '25 ebitda of ₹ -0.36 crore. This represent the growth of 102.78% The net profit of Indo Rama Synthetics (India) Ltd changed from ₹ -19.18 crore to ₹ 64.13 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Skybiotech Healthcare Limited changed from ₹ 0.25 crore to ₹ -0.3 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Indo Rama Synthetics (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Skybiotech Healthcare Limited changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Indo Rama Synthetics (India) Ltd

Incorporated on April 28, 1986, Indo Rama Synthetics (India) Limited (IRSIL) is a manufacturer of Polyester Filament Yarn (PFY), Polyester Staple Fiber (PSF), Draw Texturised Yarn (DTY), Specialty Fiber and Chips.
The Company is also engaged in trading of spun yarn and power generation, used primarily for captive consumption. The Company is India's largest dedicated polyester manufacturer with an integrated manufacturing complex at Butibori near Nagpur (Maharashtra), with an annual capacity of 6,72,000 tonnes per annum comprising Polyester Stable Fibre (PSF), Filament Yarn, Draw Texturised Yarn, Fully Drawn Yarn and Textile grade Chips.
The Company commenced business in November, 1986. In Sep.'93, IRSIL issued FCDs to part-finance its Rs 5.55-cr expansion-cum-backward integration project to manufacture partially oriented yarn (POY) and polyester staple fibre (PSF) at Butibori, near Nagpur which commenced commercial production in Mar.

About Skybiotech Healthcare Limited

Skybiotech Healthcare Limited was initially incorporated as Kapil Cotex Limited on October 14, 1983.
The Company has altered a change in name with due approval from the Registrar of Companies to Skybiotech Healthcare Limited in 2025. he Company is involved in Spinning, weaving and finishing of textiles. During the concerned year, it did not get any revenue from its main objects.
However, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.
It also deals in shares & Securities, where it earned capital gains & dividend income. Company has acquired 72.52% stake in M/s.
Skybiotech Lifescience Private Limited, making it a subsidiary of the Company in 2024.

FAQs for the comparison of Indo Rama Synthetics (India) Ltd and Skybiotech Healthcare Limited

Which company has a larger market capitalization, Indo Rama Synthetics (India) Ltd or Skybiotech Healthcare Limited?

Market cap of Indo Rama Synthetics (India) Ltd is 1,186 Cr while Market cap of Skybiotech Healthcare Limited is 38 Cr

What are the key factors driving the stock performance of Indo Rama Synthetics (India) Ltd and Skybiotech Healthcare Limited?

The stock performance of Indo Rama Synthetics (India) Ltd and Skybiotech Healthcare Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indo Rama Synthetics (India) Ltd and Skybiotech Healthcare Limited?

As of June 28, 2026, the Indo Rama Synthetics (India) Ltd stock price is INR ₹45.43. On the other hand, Skybiotech Healthcare Limited stock price is INR ₹199.95.

How do dividend payouts of Indo Rama Synthetics (India) Ltd and Skybiotech Healthcare Limited compare?

To compare the dividend payouts of Indo Rama Synthetics (India) Ltd and Skybiotech Healthcare Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.